Hematologic Malignancies
Article
Daratumumab Effective in Combo Regimen
Article
Sustained Remissions After Discontinuation of Ibrutinib in Relapsed/Refractory CLL: A Basis for Reducing Drug Toxicity and Treatment Costs?
Conference Coverage
Severe psoriasis upped lymphoma risk in large cohort study
SCOTTSDALE, ARIZ. – Psoriasis of all severities was linked to a 3.5-fold increase in risk of cutaneous T-cell lymphoma, and severe psoriasis upped...
Article
New Treatments Offer Hope in Diffuse Large B-Cell Lymphoma
National Cancer Institute researchers found that SMAC mimetics aided in the reduction of diffuse large B-cell lymphoma subtypes by mimicking...
Article
Dronabinol: A Controversial Acute Leukemia Treatment
Conference Coverage
A Rare Case of Seronegative Cat Scratch Disease Masquerading as Relapsed Hodgkin Lymphoma
Abstract 43: 2015 AVAHO Meeting
Conference Coverage
Impact of Treatment Sequencing on Outcomes and Costs in Relapsed Low-Grade or Follicular B-Cell Non-Hodgkin Lymphoma
Abstract 33: 2015 AVAHO Meeting
Article
Cytarabine Combination: Long-term Effects
New research from in vitro study found a way to reduce T-cell viability and proliferation for patients with acute myeloid leukemia.
Conference Coverage
Brentuximab Vedotin in a Patient With Aggressive Systemic Mastocytosis and Pure Red Cell Aplasia
Abstract 20: 2015 AVAHO Meeting
Conference Coverage
Telehematology: Improving Access for Veterans With Select Hematologic Disorders
Abstract 14: 2015 AVAHO Meeting